ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-17 |

Results: 17

ABNORMAL DEPOSITION OF EXTRACELLULAR-MATRIX PROTEINS BY CULTURED SMOOTH-MUSCLE CELLS FROM HUMAN VARICOSE-VEINS

Authors: SANSILVESTRIMOREL P NONOTTE I FOURNETBOURGUIGNON MP RUPIN A FABIANI JN VERBEUREN TJ VANHOUTTE PM

Citation: P. Sansilvestrimorel et al., ABNORMAL DEPOSITION OF EXTRACELLULAR-MATRIX PROTEINS BY CULTURED SMOOTH-MUSCLE CELLS FROM HUMAN VARICOSE-VEINS, Journal of vascular research, 35(2), 1998, pp. 115-123

THE DIRECT THROMBIN INHIBITOR S-18326 HAS ADDITIONAL ACTIVITY ON TISSUE FACTOR FACTOR-VIIA AND HIGH EFFICACY ON VENOUS THROMBOSIS

Authors: RUPIN A VALLEZ MO MENNECIER P DENANTEUIL G VERBEUREN TJ

Citation: A. Rupin et al., THE DIRECT THROMBIN INHIBITOR S-18326 HAS ADDITIONAL ACTIVITY ON TISSUE FACTOR FACTOR-VIIA AND HIGH EFFICACY ON VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 384-384

EFFICIENCY OF THE DIRECT THROMBIN INHIBITOR S-18326 IN A NEW CANINE MODEL OF VENOUS THROMBOSIS

Authors: VERBEUREN TJ VALLEZ MO RUPIN A VERSLUYS D SIMONET S DENANTEUIL G

Citation: Tj. Verbeuren et al., EFFICIENCY OF THE DIRECT THROMBIN INHIBITOR S-18326 IN A NEW CANINE MODEL OF VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 387-387

THE NEW ORALLY-ACTIVE THROMBIN INHIBITOR S-18326 DOES NOT POSSESS INFLAMMATORY EFFECTS AT ANTITHROMBOTIC DOSES

Authors: RUPIN A VALLEZ MO MENNECIER P COURCHAY C DENANTEUIL G VERBEUREN TJ

Citation: A. Rupin et al., THE NEW ORALLY-ACTIVE THROMBIN INHIBITOR S-18326 DOES NOT POSSESS INFLAMMATORY EFFECTS AT ANTITHROMBOTIC DOSES, Thrombosis and haemostasis, 1997, pp. 2232-2232

SELECTION OF S18326 AS A NEW POTENT AND SELECTIVE BORONIC ACID DIRECTTHROMBIN INHIBITOR

Authors: RUPIN A MENNECIER P LILA C DENANTEUIL G VERBEUREN TJ

Citation: A. Rupin et al., SELECTION OF S18326 AS A NEW POTENT AND SELECTIVE BORONIC ACID DIRECTTHROMBIN INHIBITOR, Thrombosis and haemostasis, 78(4), 1997, pp. 1221-1227

DELAYED BUT LONG-LASTING PRODUCTION OF CYCLIC-GMP BY CULTURED SMOOTH-MUSCLE CELLS FROM ATHEROSCLEROTIC AORTA IN RESPONSE TO NO

Authors: RUPIN A BEHR D VERBEUREN TJ

Citation: A. Rupin et al., DELAYED BUT LONG-LASTING PRODUCTION OF CYCLIC-GMP BY CULTURED SMOOTH-MUSCLE CELLS FROM ATHEROSCLEROTIC AORTA IN RESPONSE TO NO, British Journal of Pharmacology, 122, 1997, pp. 218-218

INCREASED ACTIVITY OF GUANYLATE-CYCLASE IN THE ATHEROSCLEROTIC RABBITAORTA - ROLE OF NON-ENDOTHELIAL NITRIC-OXIDE SYNTHASES

Authors: RUPIN A BEHR D VERBEUREN TJ

Citation: A. Rupin et al., INCREASED ACTIVITY OF GUANYLATE-CYCLASE IN THE ATHEROSCLEROTIC RABBITAORTA - ROLE OF NON-ENDOTHELIAL NITRIC-OXIDE SYNTHASES, British Journal of Pharmacology, 119(6), 1996, pp. 1233-1238

EXPRESSION OF FUNCTIONAL BRAIN AND MACROPHAGIC NO-SYNTHASES IN THE ATHEROSCLEROTIC RABBIT AORTA

Authors: RUPIN A BEHR D VERBEUREN TJ

Citation: A. Rupin et al., EXPRESSION OF FUNCTIONAL BRAIN AND MACROPHAGIC NO-SYNTHASES IN THE ATHEROSCLEROTIC RABBIT AORTA, British Journal of Pharmacology, 117, 1996, pp. 86-86

INHIBITION OF INDUCED LYMPHOCYTE-PROLIFERATION BY LIPID AND PROTEIN-COMPONENTS OF THE SYNCYTIOTROPHOBLAST PLASMA-MEMBRANE

Authors: GIRARD ACL GUILLAUMIN JM THIBAULT G RUPIN A DERUSSE J BARDOS P

Citation: Acl. Girard et al., INHIBITION OF INDUCED LYMPHOCYTE-PROLIFERATION BY LIPID AND PROTEIN-COMPONENTS OF THE SYNCYTIOTROPHOBLAST PLASMA-MEMBRANE, American journal of reproductive immunology [1989], 33(2), 1995, pp. 182-189

S-18326 IS A NEW POTENT BOROARGINIC ANTI-THROMBIN AGENT WHICH DOES NOT INTERFERE WITH FIBRINOLYSIS

Authors: RUPIN A MENNECIER P DENANTEUIL G VERBEUREN TJ

Citation: A. Rupin et al., S-18326 IS A NEW POTENT BOROARGINIC ANTI-THROMBIN AGENT WHICH DOES NOT INTERFERE WITH FIBRINOLYSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1309-1309

ANTITHROMBOTIC PROPERTIES OF S 18326 - A NEW POTENT ORALLY-ACTIVE TRIPEPTIDIC BORONIC ACID THROMBIN INHIBITOR

Authors: VERBEUREN TJ RUPIN A SIMONET S VALLEZ MO DENANTEUIL G

Citation: Tj. Verbeuren et al., ANTITHROMBOTIC PROPERTIES OF S 18326 - A NEW POTENT ORALLY-ACTIVE TRIPEPTIDIC BORONIC ACID THROMBIN INHIBITOR, Thrombosis and haemostasis, 73(6), 1995, pp. 1310-1310

IS NO INVOLVED IN THE UNUSUALLY HIGH-LEVELS OF CYCLIC-GMP DETECTED INTHE ATHEROSCLEROTIC RABBIT AORTA

Authors: RUPIN A BEHR D VERBEUREN TJ

Citation: A. Rupin et al., IS NO INVOLVED IN THE UNUSUALLY HIGH-LEVELS OF CYCLIC-GMP DETECTED INTHE ATHEROSCLEROTIC RABBIT AORTA, Thrombosis and haemostasis, 73(6), 1995, pp. 1389-1389

A SCREENING-PROCEDURE TO EVALUATE THE ANTICOAGULANT ACTIVITY AND THE KINETIC-BEHAVIOR OF DIRECT THROMBIN INHIBITORS

Authors: RUPIN A MENNECIER P DENANTEUIL G LAUBIE M VERBEUREN TJ

Citation: A. Rupin et al., A SCREENING-PROCEDURE TO EVALUATE THE ANTICOAGULANT ACTIVITY AND THE KINETIC-BEHAVIOR OF DIRECT THROMBIN INHIBITORS, Thrombosis research, 78(3), 1995, pp. 217-225

PREFERENTIAL USE OF DILUTIONS OF SINGLE SERA THAN MIXTURE OF SERA TO STANDARDIZE THE QUANTITATION OF ANTICARDIOLIPIN ANTIBODIES

Authors: RUPIN A REBER G BARDOS P DEMOERLOOSE P

Citation: A. Rupin et al., PREFERENTIAL USE OF DILUTIONS OF SINGLE SERA THAN MIXTURE OF SERA TO STANDARDIZE THE QUANTITATION OF ANTICARDIOLIPIN ANTIBODIES, Thrombosis research, 75(4), 1994, pp. 465-471

THE PREFERENTIAL USE OF AN ANTICARDIOLIPIN POSITIVE SERUM TO STANDARDIZE THE ANTICARDIOLIPIN ANTIBODIES QUANTIFICATION

Authors: RUPIN A REBER G GRUEL Y BARDOS P DEMOERLOOSE P

Citation: A. Rupin et al., THE PREFERENTIAL USE OF AN ANTICARDIOLIPIN POSITIVE SERUM TO STANDARDIZE THE ANTICARDIOLIPIN ANTIBODIES QUANTIFICATION, Thrombosis and haemostasis, 69(6), 1993, pp. 1032-1032

THE PREFERENTIAL USE OF AN ANTICARDIOLIPIN POSITIVE SERUM TO STANDARDIZE THE ANTICARDIOLIPIN ANTIBODIES QUANTIFICATION

Authors: RUPIN A REBER G GRUEL Y BARDOS P DEMOERLOOSE P

MICROASSAYS TO COMPARE ANTI-THROMBIN PROPERTIES OF POTENTIAL ANTI-THROMBOTICS

Authors: RUPIN A MENNECIER P LAUBIE M VERBEUREN TJ

Citation: A. Rupin et al., MICROASSAYS TO COMPARE ANTI-THROMBIN PROPERTIES OF POTENTIAL ANTI-THROMBOTICS, Thrombosis and haemostasis, 69(6), 1993, pp. 1318-1318

Risultati: 1-17 |